Mark A. Hillman
Hillman Value Fund
Mark A. Hillman Pfizer Inc stake
total: 75
Hillman Value Fund PFE trades
- Total transactions:
- 10
- New positions:
- 2
- Sold out:
- 1
- Added:
- 3
- Reduced:
- 4
- Held since:
- 2023 Q4
- Held for:
- 10 quarters
- Latest activity:
- 2025 Q4
According to 2026 Q1 report, Mark A. Hillman holds 92,700 Pfizer Inc (PFE) shares with a market value of roughly $2.60M accounting for 3.14% of the overall portfolio. To date, the estimated cost basis is nearly $28.61 for "buy" trades and estimated average "sell" price is $25.22. Hillman Value Fund first purchased PFE in 2020 Q1, initially acquiring 81,500 shares. Mark A. Hillman later completely sold out the position and invested in Pfizer Inc again in 2023 Q4. Since the initial investment in Pfizer Inc (PFE), Hillman Value Fund has made 9 more transactions.
When did Mark A. Hillman buy Pfizer Inc (PFE)?
Mark A. Hillman first invested in Pfizer Inc (PFE) in 2020 Q1 at the reported quarter-end price of $32.64 per share.
What's the cost basis of Hillman Value Fund's PFE stake?
The estimated cost basis for Pfizer Inc (PFE) stake is around $28.61 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $28.61
- Weighted AVG sell price:
- $25.22
Mark A. Hillman's historical trades in Pfizer Inc
10 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q4
|
2.46%
|
92,700
|
$24.90
|
$2,308,230
|
-18.18% (-20,600)
|
-0.49%
|
|
2025 Q3
|
2.75%
|
113,300
|
$25.48
|
$2,886,884
|
-13.51% (-17,700)
|
-0.38%
|
|
2025 Q2
|
2.68%
|
131,000
|
$24.24
|
$3,175,440
|
-5.89% (-8,200)
|
-0.14%
|
|
2025 Q1
|
2.48%
|
139,200
|
$25.34
|
$3,527,328
|
-37.07% (-82,000)
|
-0.98%
|
|
2024 Q1
|
2.53%
|
221,200
|
$27.75
|
$6,138,300
|
+21.53% (+39,191)
|
+0.45%
|
|
2023 Q4
|
2.26%
|
182,009
|
$28.79
|
$5,240,039
|
new
|
+2.26%
|
|
2021 Q4
|
0.00%
|
0
|
$43.01
|
|
-100% (-159,000)
|
-3.17%
|
|
2021 Q1
|
3.33%
|
159,000
|
$36.23
|
$5,760,570
|
+59.80% (+59,500)
|
+1.25%
|
|
2020 Q4
|
2.78%
|
$36.81
|
+22.09% (+18,000)
|
|||
|
2020 Q1
|
3.71%
|
$32.64
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.